Franck Barrat
12Patents
5h-index
8Co-inventors
59Inventor score
Filing activity: Oct 3, 2001 → Nov 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8940310B2 | Methods of treatment using TLR7 and/or TLR9 inhibitors | Emerging Cross-Sectional Technologies | 13 | Active |
| US9868955B2 | Human toll-like receptor inhibitors and methods of use thereof | Chemistry; Metallurgy | 11 | Active |
| US8759305B2 | Methods and compositions for inhibition of innate immune responses and autoimmunity | Chemistry; Metallurgy | 9 | Active |
| US9228184B2 | Human toll-like receptor inhibitors and methods of use thereof | Chemistry; Metallurgy | 8 | Active |
| US6670146B2 | Regulatory T cells; methods | Chemistry; Metallurgy | 8 | Expired |
| US8962579B2 | Methods and compositions for inhibition of immune responses and autoimmunity | Chemistry; Metallurgy | 4 | Active |
| US11197890B2 | Methods of treating cancer, infectious disease, and autoimmune disease using CXC chemokines | Human Necessities | 1 | Active |
| US9063123B2 | Transgenic mice expressing human toll-like receptor 8 | Chemistry; Metallurgy | 1 | Active |
| US9347064B2 | Methods of treatment using TLR7 and/or TLR9 inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US9476053B2 | Methods and compositions for inhibition of immune responses and autoimmunity | Chemistry; Metallurgy | 0 | Active |
| US12427183B2 | Methods of treating cancer, infectious disease, and autoimmune disease using chemokines | Emerging Cross-Sectional Technologies | 0 | Active |
| US7122340B2 | Regulatory T cells; methods | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.